Abstract

The gut microbiota, a diverse collection of microorganisms in the gastrointestinal tract, plays a critical role in regulating metabolic, immune, and cognitive functions. Disruptions in the composition of these microbial communities, termed dysbiosis, have been linked to various neurodegenerative diseases (NDs), such as Parkinson's disease (PD) and Alzheimer's disease (AD). One of the key pathological features of NDs is neuroinflammation, which involves the activation of microglia and peripheral immune cells. The gut microbiota modulates immune responses through the production of metabolites and interactions with immune cells, influencing the inflammatory processes within the central nervous system. This review explores the impact of gut dysbiosis on neuroinflammation, focusing on the roles of microglia, immune cells, and potential therapeutic strategies targeting the gut microbiota to alleviate neuroinflammatory processes in NDs.

MeSH

Dysbiosis, Microglia, Cells, Alzheimer Disease, Immune System, Gastrointestinal Microbiome, Neurodegenerative Diseases, Microbiota

Cited by

• Microbiome Gut-Brain-Axis: Impact on Brain Development and Mental Health. Mol Neurobiol, 2025
• Age-Related Cognitive Decline and Dementia: Interface of Microbiome-Immune-Neuronal Interactions. J Gerontol A Biol Sci Med Sci, 2025
• The Role of Genetic, Environmental, and Dietary Factors in Alzheimer's Disease: A Narrative Review. Int J Mol Sci, 2025
• Gut microbiome is associated with radiotherapy response in lung cancer patients with brain metastases. Front Cell Infect Microbiol, 2025
• Could a Mediterranean Diet Modulate Alzheimer's Disease Progression? The Role of Gut Microbiota and Metabolite Signatures in Neurodegeneration. Foods, 2025